|
Soler-Espejo E., Marín F., López-Gálvez R., Ramos-Bratos M.P., Sánchez-Villalobos M., Esteve-Pastor M.A., Lip G.Y.H., Rivera-Caravaca J.M., Roldán V. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study. Clinical Cardiology. February 2025. 48. 10.1002/clc.70102
AÑO: 2025; IF: 2.3
|
|
López-Gálvez R., Orenes-Piñero E., Rivera-Caravaca J.M., Pérez-Sanz F., Ramos-Bratos M.P., Roca M.I., Mandaglio-Collados D., López-García C., Gil-Pérez P., Esteve-Pastor M.A., Marín F. Microbial Insights: The Role of Diet in Modulating Gut Microbiota and Metabolites After Acute Coronary Syndrome. Molecular Nutrition and Food Research. 2025. 10.1002/mnfr.70046
AÑO: 2025; IF: 4.2
|
|
Caballero I., Mbouamboua Y., Weise S., López-Gálvez R., Couralet M., Fleurot I., Pons N., Barrera-Conde M., Quílez-Playán N., Keller M., Klymiuk N., Robledo P., Hummel T., Barbry P., Chamero P. Cystic fibrosis alters the structure of the olfactory epithelium and the expression of olfactory receptors affecting odor perception. Science Advances. 28 February 2025. 11. 10.1126/sciadv.ads1568
AÑO: 2025; IF: 12.5
|
|
Rivera-Caravaca JM, Soler-Espejo E, Ramos-Bratos MP, Lopez-Galvez R, Gonzalez-Lozano E, Lip GYH, Marin F, Roldan V. The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation. Cardiovasc Diabetol. 2025 Jul 10;24(1):281. doi: 10.1186/s12933-025-02809-2. PubMed PMID: 40640827; PubMed Central PMCID: PMC12247220.
AÑO: 2025; IF: 10.6
|
|
Soler-Espejo E, Zazo-Luengo BA, Rivera-Caravaca JM, Lopez-Gavez R, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation. J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29. PubMed PMID: 39615399.
AÑO: 2025; IF: 4.0
|